Riskpilot← Back to searchSign inGet full accessHAMMEKEN CELLARS DANMARK APS
APSActiveCVR 35049975Frydendalsvej 3, st.Wholesale of beverages · NACE 4634Est. 20131 employees
Revenue 2024
DKK 2,8M
+242% vs 2023
EBITDA margin
91.2%
+423% vs 2023
Equity ratio
17.6%
Financial strength
Net profit 2024
DKK 2M
+404% vs 2023
| Revenue | DKK 2,8M | +242% |
| EBITDA | DKK 2,5M | +423% |
| Net profit | DKK 2M | +404% |
| Total assets | DKK 13,7M | +104% |
| Equity | DKK 2,4M | +192% |
| Employees | 1 | — |
Legal name
HAMMEKEN CELLARS DANMARK APS
CVR number
35049975
Legal form
Anpartsselskab
NACE code
4634 · Wholesale of beverages
Founded
28. februar 2013
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion
Company purpose
Selskabets formål er handel med vin og anden dermed beslægtet virksomhed
Address
Frydendalsvej 3, st.
Phone
+4540302942
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.779 | 6.577 | 3.930 | 7.547 | 10.851 | 16.940 | 428 | 334 | 875 | 777 | 815 | 2.789 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -329 | -247 |
| EBITDA | -45 | 210 | 111 | 384 | 609 | 115 | 428 | -96 | 875 | 777 | 486 | 2.543 |
| Depreciation & amort. | -0 | -4 | -5 | -5 | -5 | -5 | -1 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -45 | 205 | 106 | 378 | 603 | 110 | 427 | -96 | 875 | 777 | 486 | 2.543 |
| Net financials | -30 | -2 | -1 | 3 | -69 | 24 | 28 | 7 | 0 | -21 | 17 | 5 |
| Profit before tax | -51 | 204 | 105 | 381 | 534 | 134 | 455 | -89 | 875 | 756 | 503 | 2.548 |
| Tax | 12 | 50 | 27 | 84 | 118 | 29 | 100 | -20 | 193 | 148 | 111 | 571 |
| Net profit | -63 | 154 | 78 | 297 | 417 | 105 | 355 | -70 | 683 | 608 | 392 | 1.977 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.984 | 1.290 | 977 | 1.506 | 1.410 | 1.986 | 1.900 | 2.114 | 19.342 | 1.746 | 6.730 | 13.713 |
| Equity | 17 | 171 | 249 | 546 | 513 | 282 | 637 | 193 | 875 | 962 | 825 | 2.410 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.968 | 1.119 | 728 | 960 | 896 | 1.704 | 1.263 | 1.921 | 18.466 | 784 | 5.905 | 11.303 |
| Total debt | 2.968 | 1.119 | 728 | 960 | 896 | 1.704 | 1.263 | 1.921 | 18.466 | 784 | 5.905 | 11.303 |
EBITDA margin
91.2%
This company
15.8%
Market median
+477% vs market
20132024
Equity ratio
17.6%
This company
38.2%
Market median
-54% vs market
20132024
Return on equity
82.0%
This company
18.4%
Market median
+346% vs market
20132024
Net profit margin
70.9%
This company
8.1%
Market median
+775% vs market
20132024
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20132024
Debt / equity
4.69×
This company
0.62×
Market median
-656% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-02-28 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NM Management | Management | 2013 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HAMMEKEN CELLARS DANMARK APS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nicholas Michael Hammeken | Management | 0 companies |